Works by Hasegawa, Seiji

Results: 34
    1
    2
    3

    Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001).

    Published in:
    Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 6, p. 565, doi. 10.1007/s00280-024-04648-6
    By:
    • Ozawa, Mayumi;
    • Watanabe, Jun;
    • Ishibe, Atsushi;
    • Goto, Koki;
    • Fujii, Yoshiro;
    • Nakagawa, Kazuya;
    • Suwa, Yusuke;
    • Suwa, Hirokazu;
    • Masui, Hidenobu;
    • Sugita, Mitsutaka;
    • Mochizuki, Yasuhisa;
    • Yamagishi, Shigeru;
    • Hasegawa, Seiji;
    • Homma, Yuki;
    • Momiyama, Masashi;
    • Kumamoto, Takafumi;
    • Matsuyama, Ryusei;
    • Takeda, Kazuhisa;
    • Taguri, Masataka;
    • Endo, Itaru
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Senescent cell removal via JAG1‐NOTCH1 signalling in the epidermis.

    Published in:
    Experimental Dermatology, 2021, v. 30, n. 9, p. 1268, doi. 10.1111/exd.14361
    By:
    • Yoshioka, Hisashi;
    • Yamada, Takaaki;
    • Hasegawa, Seiji;
    • Miyachi, Katsuma;
    • Ishii, Yoshie;
    • Hasebe, Yuichi;
    • Inoue, Yu;
    • Tanaka, Hiroshi;
    • Iwata, Yohei;
    • Arima, Masaru;
    • Sugiura, Kazumitsu;
    • Akamatsu, Hirohiko
    Publication type:
    Article
    21
    22
    23
    24

    Terminal differentiation of keratinocytes was damaged in type 2 diabetic mice.

    Published in:
    Molecular Biology Reports, 2022, v. 49, n. 7, p. 5875, doi. 10.1007/s11033-022-07367-4
    By:
    • Takayanagi, Takeshi;
    • Hirai, Hiroyuki;
    • Asada, Yohei;
    • Yamada, Takaaki;
    • Hasegawa, Seiji;
    • Tomatsu, Eisuke;
    • Maeda, Yoshiteru;
    • Yoshino, Yasumasa;
    • Hiratsuka, Izumi;
    • Sekiguchi-Ueda, Sahoko;
    • Shibata, Megumi;
    • Seino, Yusuke;
    • Sugimura, Yoshihisa;
    • Akamatsu, Hirohiko;
    • Itoh, Mitsuyasu;
    • Suzuki, Atsushi
    Publication type:
    Article
    25
    26
    27
    28
    29

    ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients.

    Published in:
    2023
    By:
    • Shinto, Eiji;
    • Oki, Eiji;
    • Shimokawa, Mototsugu;
    • Yamaguchi, Shigeki;
    • Ishiguro, Megumi;
    • Hasegawa, Seiji;
    • Takii, Yasumasa;
    • Ishida, Hideyuki;
    • Kusumoto, Tetsuya;
    • Morita, Masaru;
    • Tomita, Naohiro;
    • Shiozawa, Manabu;
    • Tanaka, Masafumi;
    • Ozawa, Heita;
    • Hashiguchi, Yojiro;
    • Ohnuma, Shinobu;
    • Tada, Sachiyo;
    • Matsushima, Tomoko;
    • Yamagishi, Keisuke;
    • Hase, Kazuo
    Publication type:
    Abstract
    30

    Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 8, p. 5239, doi. 10.1245/s10434-023-13594-1
    By:
    • Shinto, Eiji;
    • Oki, Eiji;
    • Shimokawa, Mototsugu;
    • Yamaguchi, Shigeki;
    • Ishiguro, Megumi;
    • Hasegawa, Seiji;
    • Takii, Yasumasa;
    • Ishida, Hideyuki;
    • Kusumoto, Tetsuya;
    • Morita, Masaru;
    • Tomita, Naohiro;
    • Shiozawa, Manabu;
    • Tanaka, Masafumi;
    • Ozawa, Heita;
    • Hashiguchi, Yojiro;
    • Ohnuma, Shinobu;
    • Tada, Sachiyo;
    • Matsushima, Tomoko;
    • Yamagishi, Keisuke;
    • Hase, Kazuo
    Publication type:
    Article
    31
    32
    33
    34